Breast Biopsy Devices Market to Grow with a CAGR of 6.69% through 2029

An increase in the incidence of breast cancer is expected to drive the Global Breast Biopsy Devices Market growth in the forecast period, 2025-2029. 

 

According to TechSci Research report, “Breast Biopsy Devices Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029F”, the Global Breast Biopsy Devices Market stood at USD 0.84 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 6.69% through 2029. The current growth surge in the global biopsy devices market is fueled by several converging factors highlighting the critical need for effective cancer diagnosis and treatment. One major driver is the increasing prevalence of cancer worldwide, particularly in emerging economies like those in the Asia Pacific region. As healthcare infrastructure improves in these areas, there's a rising demand for advanced diagnostic tools such as biopsy devices. The market's swift resurgence post-pandemic, driven by rising cancer cases, underscores the urgency for reliable diagnostic solutions. Ongoing advancements in oncology and biopsy device technology further sustain market momentum by enhancing diagnostic accuracy and treatment efficacy. The evolving oncology landscape, marked by new product launches and a robust biopsy device pipeline, presents lucrative opportunities for industry stakeholders.

Minimally invasive medical procedures have become integral to modern healthcare, offering benefits like reduced recovery time and trauma. There's a noticeable shift towards minimally invasive surgeries, with patients showing higher satisfaction levels compared to traditional procedures. Manufacturer research supports this trend, showing a preference for disposable biopsy devices facilitating minimally invasive approaches. The increasing demand for less invasive surgeries and disposable biopsy devices is expected to drive market expansion in the foreseeable future. Technological advancements in biopsy guidance systems, like vacuum-assisted guns, are gaining attention for their precision and efficiency, leading to better diagnostic outcomes and patient experiences. The growing elderly population, combined with the introduction of cost-effective and advanced biopsy devices, is anticipated to further boost market growth in the coming years.

                          

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Breast Biopsy Devices Market”

The Global Breast Biopsy Devices Market is segmented into Type, Procedure, Application, End User, Regional Distribution, and Company.

Based on end user, the Hospitals & Surgical Centers segment dominated the global Breast Biopsy Devices Market during the forecast period. Hospitals and surgical centers play pivotal roles in delivering comprehensive healthcare, offering a wide range of diagnostic and treatment services, including breast biopsy procedures. These facilities boast cutting-edge medical infrastructure, advanced imaging technologies, and proficient healthcare professionals, making them optimal environments for conducting precise and accurate breast biopsy procedures. A key factor contributing to the dominance of hospitals and surgical centers in the breast biopsy devices market is their capacity to deliver holistic care to patients throughout their diagnostic and treatment journeys. Patients with suspected breast abnormalities often choose to undergo evaluation and management in hospital settings due to the presence of multidisciplinary teams comprising radiologists, oncologists, surgeons, and pathologists. This collaborative approach ensures patients receive timely and coordinated care, from initial diagnosis to treatment planning and follow-up.

Based on region, Asia Pacific emerged as the fastest growing region in the global market of breast biopsy devices during the forecast period. The growing incidence of breast cancer in the region has resulted in heightened demand for diagnostic and treatment solutions, including breast biopsy devices. As healthcare infrastructure improves across various countries in the Asia Pacific, more individuals gain access to screening and diagnostic services, consequently increasing the demand for breast biopsy procedures. Increased awareness of breast health and cancer screening initiatives, supported by government efforts, has facilitated the early detection of breast abnormalities, further driving the demand for biopsy devices. Advancements in healthcare technology and the presence of skilled medical professionals are also playing significant roles in driving growth in the breast biopsy devices market in the Asia Pacific. With healthcare facilities increasingly equipped with cutting-edge equipment and expertise, they are better positioned to provide improved diagnostic and treatment options, including breast biopsy procedures.

 

Major companies operating in Global Breast Biopsy Devices Market are:

• Hologic Inc.
• Danaher Corporation
• Becton, Dickinson and Company
• Argon Medical Devices, Inc.
• Guardant Health, Inc.
• Merit Medical Systems, Inc.
• Neogenomics Laboratories, Inc. 
• Sysmex Inostics, Inc.
• Sterylab S.R.L.
• Bio-Rad Laboratories Inc.

 

Download Free Sample Report

Customers can also request 10% free customization on this report

 

“Favorable market conditions, including widespread adoption of advanced devices like vacuum-assisted biopsy systems and increasing demand for disposable devices, are projected to benefit the regional market. The ongoing enhancement of healthcare infrastructure in developing nations, coupled with significant unmet patient needs and rising cancer rates, is expected to drive regional market growth. Major market players are prioritizing research and development efforts to create technologically advanced products, aiming to maintain a robust market position”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Breast Biopsy Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Others), By Procedure (Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy), By Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By End User (Hospitals & Surgical Centers, Breast Care Centers, Imaging Clinics & Diagnostic Centers), By Region and Competition, 2019-2029F, has evaluated the future growth potential of Global Breast Biopsy Devices Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Breast Biopsy Devices Market.

Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: [email protected]               

Website: www.techsciresearch.com